Finance

Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks

Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Nasdaq sinks more than 2% as investors raise questions about AI debt